MOLE SOLUTIONS LIMITED

Financial Health Score: D (Stable but Comatose)

Explanation: Mole Solutions Limited is not suffering from a terminal illness (insolvency), but it is currently in a medically induced coma. The company is officially dormant, meaning it has no operational pulse, no revenue, and negligible assets. While it is clinically stable—owing no money to creditors—it has hemorrhaged over £250,000 in net assets over the last decade. The score of D reflects its complete lack of operational financial health and the severe depletion of its historical capital reserves, despite being technically solvent.

Key Vital Signs

• Net Assets (Current): £100 Interpretation: This is the absolute bare minimum financial pulse a company can have. It consists solely of the nominal £100 share capital. It is a flatline; there are no retained earnings or operational reserves left in the system.
• Historical Value Hemorrhage: -99.96% decline since 2016 Interpretation: In 2016, the company had a healthy net asset base of £252,597. Over the subsequent years, this value bled out steadily (dropping to £159,740 by 2021, then £92,204 in 2022, £3,183 in 2023, and finally £100 in 2024). This indicates a long-term illness where cash reserves were either consumed by operating losses or extracted by shareholders before the company was put to sleep.
• Current Liabilities: £0 Interpretation: A clean bill of health regarding debt. The company has no external financial obligations, meaning it is not at risk of insolvency or creditor action.
• Pulse/Trading Status: Dormant Interpretation: The company has filed dormant accounts under section 480 of the Companies Act 2006. It is not trading, has no significant financial transactions, and is effectively on life support.
• Compliance Health: Excellent Interpretation: Filings are up to date, and the company is not overdue on any statutory obligations. It is maintaining its legal identity properly.

Diagnosis

Mole Solutions Limited is a corporate shell in a state of suspended animation. Historically, it was an active entity—likely involved in its stated industry of pipeline transport or underground freight, given its SIC code and website description. However, the patient suffered a chronic depletion of capital over a 6-year period (2016-2022).

Rather than collapsing into insolvency, the directors chose to effectively wind down the operational side of the business. By 2024, the remaining assets were stripped out (likely distributed as dividends or capital repayments), leaving only the £100 share capital. The company is now entirely dormant. It has no fever (debt) and no pain (trading losses), but it also has no heartbeat (revenue or activity). The lingering website describing "Underground freight transportation" is essentially a ghost of the company's past life.

Recommendations

1. Determine the Long-Term Prognosis: The directors must decide if this company is meant to wake up from its coma. If the pipeline transport concept is permanently shelved, keeping the company alive merely incurs annual administrative maintenance (like confirmation statements) without any benefit.
2. Consider a Dignified End (Voluntary Strike-Off): If there is no intention to revive the business, the most cost-effective treatment is to apply for voluntary strike-off at Companies House. This will dissolve the company cleanly, saving future administrative fees.
3. Prepare a Capital Transfusion for Resuscitation: If the intention is to eventually revive Mole Solutions to pursue the pipeline transport project, it will need a massive capital transfusion. A company cannot survive on £100 in a capital-intensive industry like infrastructure and transport. Directors should prepare a funding plan and inject fresh equity before attempting to "wake the patient up" and resume trading.
4. Update the Public Profile: If the company is to remain dormant, consider updating or removing the active website. An active website advertising services for a dormant company can send mixed signals to the market and potentially attract unwanted attention or cold calls.